BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 22277665)

  • 1. Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients.
    Iirola T; Ihmsen H; Laitio R; Kentala E; Aantaa R; Kurvinen JP; Scheinin M; Schwilden H; Schüttler J; Olkkola KT
    Br J Anaesth; 2012 Mar; 108(3):460-8. PubMed ID: 22277665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive caret.
    Venn RM; Karol MD; Grounds RM
    Br J Anaesth; 2002 May; 88(5):669-75. PubMed ID: 12067004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intravenous dexmedetomidine in children under 11 yr of age.
    Vilo S; Rautiainen P; Kaisti K; Aantaa R; Scheinin M; Manner T; Olkkola KT
    Br J Anaesth; 2008 May; 100(5):697-700. PubMed ID: 18378546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart Surgery.
    Su F; Gastonguay MR; Nicolson SC; DiLiberto M; Ocampo-Pelland A; Zuppa AF
    Anesth Analg; 2016 May; 122(5):1556-66. PubMed ID: 26218862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of long-term sufentanil infusion for sedation in ICU patients.
    Ethuin F; Boudaoud S; Leblanc I; Troje C; Marie O; Levron JC; Le Moing JP; Assoune P; Eurin B; Jacob L
    Intensive Care Med; 2003 Nov; 29(11):1916-20. PubMed ID: 12923616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients.
    Iirola T; Aantaa R; Laitio R; Kentala E; Lahtinen M; Wighton A; Garratt C; Ahtola-Sätilä T; Olkkola KT
    Crit Care; 2011; 15(5):R257. PubMed ID: 22030215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions.
    Venn RM; Grounds RM
    Br J Anaesth; 2001 Nov; 87(5):684-90. PubMed ID: 11878517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit.
    Venn M; Newman J; Grounds M
    Intensive Care Med; 2003 Feb; 29(2):201-7. PubMed ID: 12594584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of mild hypoalbuminemia on the pharmacokinetics and pharmacodynamics of dexmedetomidine in patients after major abdominal or thoracic surgery.
    Zhang T; Deng Y; He P; He Z; Wang X
    J Clin Anesth; 2015 Dec; 27(8):632-7. PubMed ID: 26277872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconsidering Dexmedetomidine for Sedation in the Critically Ill: Implications of the SPICE III Trial.
    Farina N; Alaniz C
    Ann Pharmacother; 2020 May; 54(5):504-508. PubMed ID: 31744312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects.
    Lee S; Kim BH; Lim K; Stalker D; Wisemandle W; Shin SG; Jang IJ; Yu KS
    J Clin Pharm Ther; 2012 Dec; 37(6):698-703. PubMed ID: 22650799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the use of dexmedetomidine in neurocritical care patients.
    Grof TM; Bledsoe KA
    Neurocrit Care; 2010 Jun; 12(3):356-61. PubMed ID: 20217277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%.
    Knibbe CA; Zuideveld KP; DeJongh J; Kuks PF; Aarts LP; Danhof M
    Clin Pharmacol Ther; 2002 Dec; 72(6):670-84. PubMed ID: 12496748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [THE EFFICACY AND SAFETY OF DEXMEDETOMIDINE FOR SEDATION OF PATIENTS DURING PROLONGED MECHANICAL VENTILATION IN INTENSIVE CARE UNITS (RUSSIAN MULTICENTER STUDY RESULTS)].
    Nikoda VV; Gritsan AI; Eremenko AA; Zabolotskikh IB; Kirov MY; Lebedinsky KM; Levit AL
    Anesteziol Reanimatol; 2015; 60(5):47-53. PubMed ID: 26852580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and sedative effects of dexmedetomidine in dairy calves.
    Cagnardi P; Villa R; Ravasio G; Lucatello L; Di Cesare F; Capolongo F; Boccardo A; Pravettoni D
    N Z Vet J; 2017 Jan; 65(1):14-18. PubMed ID: 27643584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remifentanil-midazolam sedation for paediatric patients receiving mechanical ventilation after cardiac surgery.
    Rigby-Jones AE; Priston MJ; Sneyd JR; McCabe AP; Davis GI; Tooley MA; Thorne GC; Wolf AR
    Br J Anaesth; 2007 Aug; 99(2):252-61. PubMed ID: 17578905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
    Riker RR; Shehabi Y; Bokesch PM; Ceraso D; Wisemandle W; Koura F; Whitten P; Margolis BD; Byrne DW; Ely EW; Rocha MG;
    JAMA; 2009 Feb; 301(5):489-99. PubMed ID: 19188334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does intranasal dexmedetomidine provide adequate plasma concentrations for sedation in children: a pharmacokinetic study.
    Miller JW; Balyan R; Dong M; Mahmoud M; Lam JE; Pratap JN; Paquin JR; Li BL; Spaeth JP; Vinks A; Loepke AW
    Br J Anaesth; 2018 May; 120(5):1056-1065. PubMed ID: 29661383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of dexmedetomidine in postsurgical pediatric intensive care unit patients: preliminary study.
    Díaz SM; Rodarte A; Foley J; Capparelli EV
    Pediatr Crit Care Med; 2007 Sep; 8(5):419-24. PubMed ID: 17693909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of piritramide after prolonged administration to intensive care patients.
    Bouillon T; Groeger P; Kietzmann D
    Eur J Anaesthesiol; 2004 Sep; 21(9):673-8. PubMed ID: 15595577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.